Pembrolizumab monotherapy in advanced NSCLC patients with low PD-L1 expression: is there real evidence?
Fiorelli, Alfonso, Vitiello, Fabiana, Morgillo, Floriana, Santagata, Mario, Spuntarelli, Chiara, Domenico, Marina Di, Santini, Mario, Bianco, AndreaVolume:
8
Journal:
Translational Cancer Research
DOI:
10.21037/tcr.2019.06.28
Date:
December, 2019
File:
PDF, 129 KB
2019